2-Acetyl-3-methylpyrazine
Common Name: |
2-Acetyl-3-methylpyrazine |
IUPAC Name: |
1-(3-methylpyrazin-2-yl)ethanone |
Molecular Formula: |
C4H9NS |
SMILES: |
CC1=NC=CN=C1C(=O)C |
Inchi: |
1S/C7H8N2O/c1-5-7(6(2)10)9-4-3-8-5/h3-4H,1-2H3 |
Inchi Key: |
QUNOTZOHYZZWKQ-UHFFFAOYSA-N |
Cas No: |
23787-80-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
103.19 |
Mass (g/mol) |
136.064 |
Molar Refractivity |
33.54 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
37.33 |
Hetero Atoms |
3 |
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
265.00 to 266.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.105 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
0.988 |
iLOGP |
1.55 |
XLOGP3 |
0.75 |
WLOGP |
0.29 |
MLOGP |
0.35 |
ESOL Log S |
-0.95 |
ESOL Solubility (mg/ml) |
11.5 |
ESOL Solubility (mol/l) |
0.112 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.11 |
Ali Solubility (mg/ml) |
7.95 |
Ali Solubility (mol/l) |
0.08 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.95 |
Silicos-IT Solubility (mg/ml) |
11.4 |
Silicos-IT Solubility (mol/l) |
0.11 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.40 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.593 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.822 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |